The Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?


Creative Commons License

Yapali S.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.24, ss.57-60, 2018 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 24 Konu: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4274/vhd.2018.0012
  • Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Sayfa Sayıları: ss.57-60

Özet

Recent advances have been made to develop and improve the serologic and molecular virologic tools for the diagnosis and optimal management of chronic hepatitis B (CHB) infection. Several biomarkers associated with the natural course of chronic hepatitis B infection virus (HBV) and the efficacy of antiviral treatment have been defined. This article reviews the impact of hepatitis B surface antigen, hepatitis B core-related antigen and HBV RNA on the natural history, treatment response and outcomes of CHB infection.